$75.74
-0.35%Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Executive Chairman & Chief Executive Officer
Compensation
$3,875,472
Executive Vice President & Chief Operating Officer
Compensation
$1,468,720
Executive Vice President & Chief Strategic Officer
Compensation
$1,575,410
Executive Vice President, Chief Strategic Officer & Executive Director
Compensation
$1,575,410
Senior Vice President & Chief Financial Officer
Compensation
$1,199,190
Senior Vice President & Chief Human Resources Officer
Senior Vice President & Chief Legal Officer
Senior Vice President & Chief Technology Officer
Senior Vice President of Global Supply Chain
Vice President & Chief Data Revenue Officer
Vice President of Corporate Finance, Chief Accounting Officer & Corporate Controller
Vice President of Investor Relations & Strategic Finance Project Officer
During the last 12 months, insiders have purchased $1.36M and sold $5.11M worth of HSIC shares, resulting in $3.75M of net selling activity.
10.0K
691.90K
4.2K
323.19K
+369K
+$369K
0
0.00
59.1K
4.79M
-4.8M
-$4.79M
0
0.00
0
0.00
+0
+$0
10.0K
670.80K
0
0.00
+671K
+$671K
Daniel William K
Director
$1.36M
Bergman Stanley M
Director, Officer: Chairman, Ceo
$4.46M
Mlotek Mark E
Officer: Evp, Chief Strategic Officer
$331K
Kuehn Kurt P
Director
$225K
Popeck Thomas C
Officer: Ceo, Henry Schein Products
$99K
Strong bearish signal with $3.75M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Weak buy/sell ratio. Selling significantly exceeds buying—monitor for potential fundamental concerns.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
4 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
HSIC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 08, 2026 | May 21, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 09, 2025 | May 22, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 10, 2024 | May 21, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 11, 2023 | April 11, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 06, 2022 | May 18, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | March 30, 2021 | May 13, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 07, 2020 | May 21, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 09, 2019 | May 22, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 12, 2018 | May 31, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | April 10, 2017 | May 31, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.